Request Sample Inquiry
Diabetic Retinopathy Market

Diabetic Retinopathy Market

Diabetic Retinopathy Market - Global Industry Assessment & Forecast

Number Of Pages # Pages:

240

Base Year:

2023

Date

Dec - 2024

Format:

PDF XLS PPT

Report Code:

VMR-3743

Segments Covered
  • By Type By Type Proliferative Diabetic Retinopathy, Non-Proliferative Diabetic Retinopathy
  • By Management By Management Vitrectomy, Anti-VEGF, Intracular Steroid, Laser Surgery
  • By Distribution Channel By Distribution Channel Hospitals and Pharmacies, Ambulatory Surgical Centers, Eye Clinics
  • By Region By Region North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Snapshot
Base YearBase Year: 2023
Forecast YearsForecast Years: 2024 - 2032
Historical YearsHistorical Years: 2018 - 2022
Revenue 2023Revenue 2023: USD 9.1 Billion
Revenue 2032Revenue 2032: USD 15.1 Billion
Revenue CAGRRevenue CAGR (2024 - 2032): 6.5%
Fastest Growing Region Fastest Growing Region (2024 - 2032) Asia Pacific
Largest Region Largest Region (2023): North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost) Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries) Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report Country/Region-specific Report
  • Go To Market Strategy Go To Market Strategy
  • Region Specific Market Dynamics Region Specific Market Dynamics
  • Region Level Market Share Region Level Market Share
  • Import Export Analysis Import Export Analysis
  • Production Analysis Production Analysis
  • Other Others Request Customization Speak To Analyst

Diabetic Retinopathy Market Segment Analysis

  • Diabetic Retinopathy Type Outlook (Revenue, USD Million, 2018 - 2030)
    • Proliferative Diabetic Retinopathy
    • Non-Proliferative Diabetic Retinopathy
  • Diabetic Retinopathy Management Outlook (Revenue, USD Million, 2018 - 2030)
    • Vitrectomy
    • Anti-VEGF
    • Intracular Steroid
    • Laser Surgery
  • Diabetic Retinopathy Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)
    • Hospitals and Pharmacies
    • Ambulatory Surgical Centers
    • Eye Clinics
  • Regional Outlook (Revenue, USD Billion/Million, 2018 - 2030)
    • North America
      • North America Diabetic Retinopathy Market, by Type
        • Proliferative Diabetic Retinopathy
        • Non-Proliferative Diabetic Retinopathy
      • North America Diabetic Retinopathy Market, by Management
        • Vitrectomy
        • Anti-VEGF
        • Intracular Steroid
        • Laser Surgery
      • North America Diabetic Retinopathy Market, by Distribution Channel
        • Hospitals and Pharmacies
        • Ambulatory Surgical Centers
        • Eye Clinics
      • U.S.
        • U.S. Diabetic Retinopathy Market, by Type
          • Proliferative Diabetic Retinopathy
          • Non-Proliferative Diabetic Retinopathy
        • U.S. Diabetic Retinopathy Market, by Management
          • Vitrectomy
          • Anti-VEGF
          • Intracular Steroid
          • Laser Surgery
        • U.S. Diabetic Retinopathy Market, by Distribution Channel
          • Hospitals and Pharmacies
          • Ambulatory Surgical Centers
          • Eye Clinics
      • Canada
        • Canada Diabetic Retinopathy Market, by Type
          • Proliferative Diabetic Retinopathy
          • Non-Proliferative Diabetic Retinopathy
        • Canada Diabetic Retinopathy Market, by Management
          • Vitrectomy
          • Anti-VEGF
          • Intracular Steroid
          • Laser Surgery
        • Canada Diabetic Retinopathy Market, by Distribution Channel
          • Hospitals and Pharmacies
          • Ambulatory Surgical Centers
          • Eye Clinics
      • Mexico
        • Mexico Diabetic Retinopathy Market, by Type
          • Proliferative Diabetic Retinopathy
          • Non-Proliferative Diabetic Retinopathy
        • Mexico Diabetic Retinopathy Market, by Management
          • Vitrectomy
          • Anti-VEGF
          • Intracular Steroid
          • Laser Surgery
        • Mexico Diabetic Retinopathy Market, by Distribution Channel
          • Hospitals and Pharmacies
          • Ambulatory Surgical Centers
          • Eye Clinics
    • Europe
      • Europe Diabetic Retinopathy Market, by Type
        • Proliferative Diabetic Retinopathy
        • Non-Proliferative Diabetic Retinopathy
      • Europe Diabetic Retinopathy Market, by Management
        • Vitrectomy
        • Anti-VEGF
        • Intracular Steroid
        • Laser Surgery
      • Europe Diabetic Retinopathy Market, by Distribution Channel
        • Hospitals and Pharmacies
        • Ambulatory Surgical Centers
        • Eye Clinics
      • U. K.
        • U.K. Diabetic Retinopathy Market, by Type
          • Proliferative Diabetic Retinopathy
          • Non-Proliferative Diabetic Retinopathy
        • U.K. Diabetic Retinopathy Market, by Management
          • Vitrectomy
          • Anti-VEGF
          • Intracular Steroid
          • Laser Surgery
        • U.K. Diabetic Retinopathy Market, by Distribution Channel
          • Hospitals and Pharmacies
          • Ambulatory Surgical Centers
          • Eye Clinics
      • France
        • France Diabetic Retinopathy Market, by Type
          • Proliferative Diabetic Retinopathy
          • Non-Proliferative Diabetic Retinopathy
        • France Diabetic Retinopathy Market, by Management
          • Vitrectomy
          • Anti-VEGF
          • Intracular Steroid
          • Laser Surgery
        • France Diabetic Retinopathy Market, by Distribution Channel
          • Hospitals and Pharmacies
          • Ambulatory Surgical Centers
          • Eye Clinics
      • Germany
        • Germany Diabetic Retinopathy Market, by Type
          • Proliferative Diabetic Retinopathy
          • Non-Proliferative Diabetic Retinopathy
        • Germany Diabetic Retinopathy Market, by Management
          • Vitrectomy
          • Anti-VEGF
          • Intracular Steroid
          • Laser Surgery
        • Germany Diabetic Retinopathy Market, by Distribution Channel
          • Hospitals and Pharmacies
          • Ambulatory Surgical Centers
          • Eye Clinics
      • Italy
        • Italy Diabetic Retinopathy Market, by Type
          • Proliferative Diabetic Retinopathy
          • Non-Proliferative Diabetic Retinopathy
        • Italy Diabetic Retinopathy Market, by Management
          • Vitrectomy
          • Anti-VEGF
          • Intracular Steroid
          • Laser Surgery
        • Italy Diabetic Retinopathy Market, by Distribution Channel
          • Hospitals and Pharmacies
          • Ambulatory Surgical Centers
          • Eye Clinics
      • Spain
        • Spain Diabetic Retinopathy Market, by Type
          • Proliferative Diabetic Retinopathy
          • Non-Proliferative Diabetic Retinopathy
        • Spain Diabetic Retinopathy Market, by Management
          • Vitrectomy
          • Anti-VEGF
          • Intracular Steroid
          • Laser Surgery
        • Spain Diabetic Retinopathy Market, by Distribution Channel
          • Hospitals and Pharmacies
          • Ambulatory Surgical Centers
          • Eye Clinics
      • Rest of Europe
        • Rest of Europe Diabetic Retinopathy Market, by Type
          • Proliferative Diabetic Retinopathy
          • Non-Proliferative Diabetic Retinopathy
        • Rest of Europe Diabetic Retinopathy Market, by Management
          • Vitrectomy
          • Anti-VEGF
          • Intracular Steroid
          • Laser Surgery
        • Rest of Europe Diabetic Retinopathy Market, by Distribution Channel
          • Hospitals and Pharmacies
          • Ambulatory Surgical Centers
          • Eye Clinics
    • Asia Pacific
      • Asia Pacific Diabetic Retinopathy Market, by Type
        • Proliferative Diabetic Retinopathy
        • Non-Proliferative Diabetic Retinopathy
      • Asia Pacific Diabetic Retinopathy Market, by Management
        • Vitrectomy
        • Anti-VEGF
        • Intracular Steroid
        • Laser Surgery
      • Asia Pacific Diabetic Retinopathy Market, by Distribution Channel
        • Hospitals and Pharmacies
        • Ambulatory Surgical Centers
        • Eye Clinics
      • China
        • China Diabetic Retinopathy Market, by Type
          • Proliferative Diabetic Retinopathy
          • Non-Proliferative Diabetic Retinopathy
        • China Diabetic Retinopathy Market, by Management
          • Vitrectomy
          • Anti-VEGF
          • Intracular Steroid
          • Laser Surgery
        • China Diabetic Retinopathy Market, by Distribution Channel
          • Hospitals and Pharmacies
          • Ambulatory Surgical Centers
          • Eye Clinics
      • Japan
        • Japan Diabetic Retinopathy Market, by Type
          • Proliferative Diabetic Retinopathy
          • Non-Proliferative Diabetic Retinopathy
        • Japan Diabetic Retinopathy Market, by Management
          • Vitrectomy
          • Anti-VEGF
          • Intracular Steroid
          • Laser Surgery
        • Japan Diabetic Retinopathy Market, by Distribution Channel
          • Hospitals and Pharmacies
          • Ambulatory Surgical Centers
          • Eye Clinics
      • Germany
        • Germany Diabetic Retinopathy Market, by Type
          • Proliferative Diabetic Retinopathy
          • Non-Proliferative Diabetic Retinopathy
        • Germany Diabetic Retinopathy Market, by Management
          • Vitrectomy
          • Anti-VEGF
          • Intracular Steroid
          • Laser Surgery
        • Germany Diabetic Retinopathy Market, by Distribution Channel
          • Hospitals and Pharmacies
          • Ambulatory Surgical Centers
          • Eye Clinics
      • India
        • India Diabetic Retinopathy Market, by Type
          • Proliferative Diabetic Retinopathy
          • Non-Proliferative Diabetic Retinopathy
        • India Diabetic Retinopathy Market, by Management
          • Vitrectomy
          • Anti-VEGF
          • Intracular Steroid
          • Laser Surgery
        • India Diabetic Retinopathy Market, by Distribution Channel
          • Hospitals and Pharmacies
          • Ambulatory Surgical Centers
          • Eye Clinics
      • South Korea
        • South Korea Diabetic Retinopathy Market, by Type
          • Proliferative Diabetic Retinopathy
          • Non-Proliferative Diabetic Retinopathy
        • South Korea Diabetic Retinopathy Market, by Management
          • Vitrectomy
          • Anti-VEGF
          • Intracular Steroid
          • Laser Surgery
        • South Korea Diabetic Retinopathy Market, by Distribution Channel
          • Hospitals and Pharmacies
          • Ambulatory Surgical Centers
          • Eye Clinics
      • South East Asia
        • South East Asia Diabetic Retinopathy Market, by Type
          • Proliferative Diabetic Retinopathy
          • Non-Proliferative Diabetic Retinopathy
        • South East Asia Diabetic Retinopathy Market, by Management
          • Vitrectomy
          • Anti-VEGF
          • Intracular Steroid
          • Laser Surgery
        • South East Asia Diabetic Retinopathy Market, by Distribution Channel
          • Hospitals and Pharmacies
          • Ambulatory Surgical Centers
          • Eye Clinics
      • Rest of Asia Pacific
        • Rest of Asia Pacific Diabetic Retinopathy Market, by Type
          • Proliferative Diabetic Retinopathy
          • Non-Proliferative Diabetic Retinopathy
        • Rest of Asia Pacific Diabetic Retinopathy Market, by Management
          • Vitrectomy
          • Anti-VEGF
          • Intracular Steroid
          • Laser Surgery
        • Rest of Asia Pacific Diabetic Retinopathy Market, by Distribution Channel
          • Hospitals and Pharmacies
          • Ambulatory Surgical Centers
          • Eye Clinics
    • Latin America
      • Latin America Diabetic Retinopathy Market, by Type
        • Proliferative Diabetic Retinopathy
        • Non-Proliferative Diabetic Retinopathy
      • Latin America Diabetic Retinopathy Market, by Management
        • Vitrectomy
        • Anti-VEGF
        • Intracular Steroid
        • Laser Surgery
      • Latin America Diabetic Retinopathy Market, by Distribution Channel
        • Hospitals and Pharmacies
        • Ambulatory Surgical Centers
        • Eye Clinics
      • Brazil
        • Brazil Diabetic Retinopathy Market, by Type
          • Proliferative Diabetic Retinopathy
          • Non-Proliferative Diabetic Retinopathy
        • Brazil Diabetic Retinopathy Market, by Management
          • Vitrectomy
          • Anti-VEGF
          • Intracular Steroid
          • Laser Surgery
        • Brazil Diabetic Retinopathy Market, by Distribution Channel
          • Hospitals and Pharmacies
          • Ambulatory Surgical Centers
          • Eye Clinics
      • Argentina
        • Argentina Diabetic Retinopathy Market, by Type
          • Proliferative Diabetic Retinopathy
          • Non-Proliferative Diabetic Retinopathy
        • Argentina Diabetic Retinopathy Market, by Management
          • Vitrectomy
          • Anti-VEGF
          • Intracular Steroid
          • Laser Surgery
        • Argentina Diabetic Retinopathy Market, by Distribution Channel
          • Hospitals and Pharmacies
          • Ambulatory Surgical Centers
          • Eye Clinics
      • Rest of Latin America
        • Rest of Latin America Diabetic Retinopathy Market, by Type
          • Proliferative Diabetic Retinopathy
          • Non-Proliferative Diabetic Retinopathy
        • Rest of Latin America Diabetic Retinopathy Market, by Management
          • Vitrectomy
          • Anti-VEGF
          • Intracular Steroid
          • Laser Surgery
        • Rest of Latin America Diabetic Retinopathy Market, by Distribution Channel
          • Hospitals and Pharmacies
          • Ambulatory Surgical Centers
          • Eye Clinics
    • Middle East & Africa
      • Middle East & Africa Diabetic Retinopathy Market, by Type
        • Proliferative Diabetic Retinopathy
        • Non-Proliferative Diabetic Retinopathy
      • Middle East & Africa Diabetic Retinopathy Market, by Management
        • Vitrectomy
        • Anti-VEGF
        • Intracular Steroid
        • Laser Surgery
      • Middle East & Africa Diabetic Retinopathy Market, by Distribution Channel
        • Hospitals and Pharmacies
        • Ambulatory Surgical Centers
        • Eye Clinics
      • GCC Countries
        • GCC Countries Diabetic Retinopathy Market, by Type
          • Proliferative Diabetic Retinopathy
          • Non-Proliferative Diabetic Retinopathy
        • GCC Countries Diabetic Retinopathy Market, by Management
          • Vitrectomy
          • Anti-VEGF
          • Intracular Steroid
          • Laser Surgery
        • GCC Countries Diabetic Retinopathy Market, by Distribution Channel
          • Hospitals and Pharmacies
          • Ambulatory Surgical Centers
          • Eye Clinics
      • South Africa
        • South Africa Diabetic Retinopathy Market, by Type
          • Proliferative Diabetic Retinopathy
          • Non-Proliferative Diabetic Retinopathy
        • South Africa Diabetic Retinopathy Market, by Management
          • Vitrectomy
          • Anti-VEGF
          • Intracular Steroid
          • Laser Surgery
        • South Africa Diabetic Retinopathy Market, by Distribution Channel
          • Hospitals and Pharmacies
          • Ambulatory Surgical Centers
          • Eye Clinics
      • Rest of Middle East & Africa
        • Rest of Middle East & Africa Diabetic Retinopathy Market, by Type
          • Proliferative Diabetic Retinopathy
          • Non-Proliferative Diabetic Retinopathy
        • Rest of Middle East & Africa Diabetic Retinopathy Market, by Management
          • Vitrectomy
          • Anti-VEGF
          • Intracular Steroid
          • Laser Surgery
        • Rest of Middle East & Africa Diabetic Retinopathy Market, by Distribution Channel
          • Hospitals and Pharmacies
          • Ambulatory Surgical Centers
          • Eye Clinics
FAQ
Frequently Asked Question
  • The global Diabetic Retinopathy valued at USD 9.1 Billion in 2023 and is expected to reach USD 15.1 Billion in 2032 growing at a CAGR of 6.5%.

  • The prominent players in the market are Bayer AG, ABBVIE Inc, Novartis AG, Alimera Sciences, Genentec Inc, Ampio Pharmaceuticals Inc, Kowa Company Ltd, BCNPeptides, Oxurion NV, Sirnaomics.

  • The market is project to grow at a CAGR of 6.5% between 2024 and 2032.

  • The driving factors of the Diabetic Retinopathy include

  • North America was the leading regional segment of the Diabetic Retinopathy in 2023.